Abstract
Although vascular endothelial growth factor (VEGF) and matrix metalloproteinase (MMP)-9 are involved in angiogenesis of various cancers, clinical utility of preoperative serum concentration of these molecules in non-small cell lung cancer (NSCLC) has not yet been elucidated. In this study, we determined the concentration of VEGF, MMP-9 and various other tumor markers in serum prior to surgery and evaluated the results compared with intratumoral vasculature to isolate a valuable marker in determining the prediction of angiogenesis in NSCLC. Among these molecules and serum tumor markers, circulating serum VEGF was identified to markedly correlate with microvessel density (MVD) of the resected tumor specimens. Moreover, overall survival of patients with low VEGF levels (≤326 ng/ml) was significantly greater than that of patients with high VEGF levels (>326 ng/ml), while patients with low MMP-9 levels (≤189 ng/ml) and those with high MMP-9 levels (>189 ng/ml) revealed similar overall survival. Conclusively, preoperative concentration of serum VEGF may be the most valuable marker in the prediction of intratumoral angiogenesis and prognosis of patients with NSCLC.
Similar content being viewed by others
References
J Adams P Carder S Downey et al. (2000) ArticleTitlevascular endothelial growth factor (VEGF) in breast cancer: comparison of plasma, serum, and tissue VEGF and microvessel density and effects of tamxifen Cancer Res 60 2898–2905
H Aikawa H Takahashi S Fujimura et al. (1999) ArticleTitleImmunohistochemical study of tumor angiogenic facotrs in non-small cell lung cancer Anticancer Res 19 4305–4309
A Balsari J Maier I Maria S Menard (1999) ArticleTitleCorrelation between growth factor production by tumor cells, serum vascular endothelial growth factor levels, and serum angiogenic activity in patients with breast carcinoma Lab Invest 79 897–902
R Bicknell A Harris (1991) ArticleTitleNovel growth regulatory factors and tumor angiogenesis Eur J Cancer 1991 781–784
G Byrne N Bundred (2000) ArticleTitleSurrogate markers of tumoral angiogenesis Int J Biol Markers 15 334–339
G Callagy E Dimitriadis J Harmey D Bouchier-Hayes M Leader E Kay (2000) ArticleTitleImmunohistochemical measurement of tumor vascular endothelial growth factor in breast cancer. A more reliable predictor of tumor stage than microvessel density or serum vascular endothelial growth factor Appl Immunohistochem Mol Morphol 8 104–109
J Choi H Kirn H Lim et al. (2001) ArticleTitleVascular endothelial growth factor in the serum of patients with non-small cell lung cancer: correlation with platelet and leukocyte counts Lung Cancer 33 171–179
G Cox JL Jones A Andi DA Waller KJ O’Byrne (2001) ArticleTitleA biological staging model for operable non-small cell lung cancer Thorax 56 561–566
M Davies S Jonas S Kaur T Allen-Mersh (2000) ArticleTitlePlasma vascular endothelial but not fibroblast growth factor levels correlate with colorectal liver metastasis vascularity and volume Br J Cancer 82 1004–1008
D Dhar T Ono A Yamanoi et al. (2002) ArticleTitleSerum endostatin predicts tumor vascularity in hepatocellular carcinoma Cancer 95 2188–2195
J Folkman K Watson D Ingber D Hanahan (1989) ArticleTitleInduction of angiogenesis during the transition from hyperplasia to neoplasia Nature 339 58–61
G Fontanini S Vignati L Boldrini et al. (1997) ArticleTitleVascular endothelial growth factor is associated with neovascularization and influences progression of non-small cell lung carcinoma Clin Cancer Res 3 861–865
A Giatromanolaki (2000) ArticleTitleDifferential expression of angiogenic and of vascular survival factors in non-small cell lung cancer (NSCLC) Adv Exp Med Biol 476 291–295
DJ Harpole W Richard JN Herndon D Sugarbaker (1996) ArticleTitleAngiogenesis and molecular biologic substaging in patients with stage I non-small cell lung cancer Ann Thorac Surg 61 1470–1476
L Hefler C Tempfer A Obermair et al. (1999) ArticleTitleSerum concentrations of vascular endothelial growth factor in vulvar cancer Clin Cancer Res 5 2806–2809
H Imoto T Osaki S Taga A Ohgami Y Ichiyoshi K Yasumoto (1998) ArticleTitleVascular endothelial growth factor expression in non-small-cell lung cancer: prognostic significance in squamous cell carcinoma J Thorac Cardiovasc Surg 115 1007–1014
B Johnson (2003) ArticleTitleAdjuvant chemotherapy for non-small cell lung cancer: the end of the beginning J Natl Cancer Inst 95 1422–1424
S Kaneko K Ishikawa I Yoshimi et al. (2003) ArticleTitleProjection of lung cancer mortality in Japan Cancer Sci 94 919–923
E Laack A Kohler C Kugler et al. (2002) ArticleTitlePretreatment serum levels of matrix metalloproteinase-9 and vascular endothelial growth factor in non-small-cell lung cancer Ann Oncol 13 1550–1557
T Lantzsch L Hefler U Krause et al. (2002) ArticleTitleThe correlation between immunohistochemically-detected markers of angiogenesis and serum vascular endothelial growth factor in patients with breast cancer Anticancer Res 22 1925–1928
T Marugome S Mizuno (2003) ArticleTitleMortality trend of lung cancer in Japan: 1960–2000 Jpn J Clin Oncol 33 148–149
J Mattern R Koomagi M Volm (1999) ArticleTitleBiological characterization of subgroups of squamous cell lung carcinomas Clin Cancer Res 5 1459–1463
J Mattern R Koomaqi M Volm (1996) ArticleTitleAssociation of vascular endothelial growth factor expression with intratumoral microvessel density and tumour cell proliferation in human epidermoid carcinoma Br J Cancer 73 931–934
KJ O’Byrne N Dobbs D Propper K Smith A Harris (1999) ArticleTitleVascular endothelial growth factor platelet counts, and prognosis in renal cancer Lancet 353 1494–1495
F Riedel K Gotte J Schwalb W Bergler K Hormann (2000) ArticleTitleExpression of 92-kDa type IV collagenase correlates with angiogenic markers and poor survival in head and neck squamous cell carcinoma Int J Oncol 17 1099–1105
R Salgado P Vermeulen I Benoy et al. (1999) ArticleTitlePlatelet number and interleukin-6 correlate with VEGF but not with bFGF serum levels of advanced cancer patients Br J Cancer 80 892–897
P Salven A Orpana H Joensuu (1999) ArticleTitleLeukocytes and platelets of patients with cancer contain high levels of vasular endothelial growth factor Clin Cancer Res 5 487–491
Y Shou T Hirano Y Gong et al. (2001) ArticleTitleInfluence of angiogenetic factors and matrix metalloproteinase upon tumour progression in non-small-cell lung cancer Br J Cancer 85 1706–1712
M Tamura Y Ohta T Kajita et al. (2001) ArticleTitlePlasma VEGF concentration can predict the tumor angiogenic capacity in non-small cell lung cancer Oncol Rep 8 1097–1102
H Verheul K Hoekman S Luykx-de Bakker et al. (1997) ArticleTitlePlatelet: transporter of vascular endothelial growth factor Clin Cancer Res 3 2187–2190
M Volm R Koomagi J Mateern T Efferth (2002) ArticleTitleProtein expression profile of primary human squamous cell lung carcinomas indicative of the incidence of metastases Clin Exp Metastasis 29 457–464
N Weidner J Folkman F Pozza (1992) ArticleTitleTumor angiogenesis: a new significant and independent prognostic indicator in early-stage breast carcinoma J Natl Cancer Inst 84 1875–1887
A Yuan CJ Yu WJ Chen et al. (2000) ArticleTitleCorrelation of total VEGF mRNA and protein expression with histologic type, tumor angiogenesis, patient survival and timing of relapse in non-small-cell lung cancer Int J Cancer 89 475–483
Acknowlegments
We thank Kazue Shimizu for her excellent technical assistance.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Shimanuki, Y., Takahashi, K., Cui, R. et al. Role of Serum Vascular Endothelial Growth Factor in the Prediction of Angiogenesis and Prognosis for Non-small Cell Lung Cancer. Lung 183, 29–42 (2005). https://doi.org/10.1007/s00408-004-2521-4
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/s00408-004-2521-4